Gossypol blood levels and inhibition of spermatogenesis in men taking gossypol as a contraceptive - A multicenter, international, dose-finding study

Citation
Em. Coutinho et al., Gossypol blood levels and inhibition of spermatogenesis in men taking gossypol as a contraceptive - A multicenter, international, dose-finding study, CONTRACEPT, 61(1), 2000, pp. 61-67
Citations number
16
Categorie Soggetti
Reproductive Medicine","da verificare
Journal title
CONTRACEPTION
ISSN journal
00107824 → ACNP
Volume
61
Issue
1
Year of publication
2000
Pages
61 - 67
Database
ISI
SICI code
0010-7824(200001)61:1<61:GBLAIO>2.0.ZU;2-9
Abstract
The safety and efficacy of gossypol continues to be controversial. The aim of this study was to evaluate gossypol as a contraceptive pill for men at d oses lower than those previously prescribed and in men from various ethnic origin. A total of 151 men from Brazil, Nigeria, Kenya, and China were divi ded into two groups. Both groups received 15 mg gossypol/day for 12 or 16 w eeks to leach spermatogenesis suppression. Subjects were then randomized to either 7.5 or 10 mg/day for 40 weeks. In addition, 51 men were enrolled as a control group. In all, 81 subjects attained spermatogenesis suppression. Only one man discontinued treatment because of tiredness. Potassium levels fluctuated within the normal range. FSH increased consistently. Testicular volume decreased, but after discontinuation, values returned to levels not statistically different from admission. Of 19 subjects on the 7.5 mg/day d ose group, 12 recovered sperm counts >20 million/mL within 12 months of dis continuing gossypol. In the 10 mg/day group, sperm counts recovered in only 10 of 24 subjects. Eight of the 43 patients remained azoospermic 1 year af ter stopping gossypol. All men diagnosed with varicocele failed to reverse spermatogenesis suppression. Gossypol blood levels indicated that sperm sup pression occurs independently of concentration, whereas spermatogenesis rec overy appears to be concentration-dependent. Gossypol may become a medical alternative to surgical vasectomy when the delay in onset of infertility is acceptable. When taken for 1 year, gossypol causes no reduction in sexual desire or frequency of intercourse. The possibility of reversal, occurring in 51% of the men on this regimen within 1 year after stopping gossypol, is an advantage of this compound as compared with surgical sterilization in m any parts of the world. CONTRACEPTION 2000;61:61-67 (C) 2000 Elsevier Scien ce Inc. All rights reserved.